RT @FlorinDanPopesc: #Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug…
RT @FlorinDanPopesc: #Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug…
RT @FlorinDanPopesc: #Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug…
RT @FlorinDanPopesc: #Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug…
RT @FlorinDanPopesc: #Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug…
#Anaphylaxis to i.v. iron products is of great clinical concern due to life-threatening potential [Ehlken et al. Drug Saf. 2018 Dec] https://t.co/b2pHMXale5
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017 #openaccess https://t.co/Xn72r2Qhe
RT @CheloXPtw: Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) i…
Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) isomaltoside 1000 in Europe based on data from EudraVigilance and VigiBase between 2014 and 2017 https://t.co/1M9mSL6o9T https://t.co